MRK 8-K 2026-08-04

Merck & Co., Inc. (MRK) 8-K dated 2026-08-04 — accession 0001104659-26-090045. This URL is the filing, not the MRK hub.

Merck & Co., Inc. (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..

Merck & Co., Inc. filed a 8-K on 2026-08-04. Accession 0001104659-26-090045.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.

Not investment advice. The MRK SEC hub lists recent forms. The stock page is the research view.